Overview
Moyamoya disease with early-onset achalasia is an extremely rare condition that combines two distinct medical problems. Moyamoya disease is a condition affecting the blood vessels in the brain. In this disease, certain arteries at the base of the brain become narrowed or blocked over time. The body tries to compensate by growing tiny new blood vessels, which on imaging look like a "puff of smoke" (the Japanese meaning of "moyamoya"). This can lead to strokes, mini-strokes (called transient ischemic attacks), headaches, and seizures. Achalasia is a disorder of the esophagus — the tube that carries food from the mouth to the stomach. In achalasia, the muscles of the esophagus do not work properly, making it very difficult to swallow food and liquids. In this combined syndrome, achalasia appears unusually early in life, often during childhood, which is much younger than typical achalasia cases. The combination of these two conditions in the same person suggests a shared underlying genetic cause, though the exact gene responsible has not been fully established in all cases. Treatment focuses on managing each condition separately: surgical procedures to improve blood flow in the brain for moyamoya, and procedures or surgery to help with swallowing for achalasia. Because both conditions can worsen over time, early diagnosis and ongoing monitoring by multiple specialists are very important.
Key symptoms:
Difficulty swallowing food and liquidsRegurgitation of undigested foodChest pain or discomfort after eatingWeight loss or poor weight gain in childrenSevere headachesStroke or mini-stroke symptoms such as sudden weakness on one side of the bodySeizuresSpeech difficultiesNumbness or tingling in the face or limbsVision changesInvoluntary movementsCognitive difficulties or learning problemsFatigue
Clinical phenotype terms (8)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Moyamoya disease with early-onset achalasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Moyamoya disease with early-onset achalasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Moyamoya disease with early-onset achalasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Moyamoya disease with early-onset achalasia.
Community
No community posts yet. Be the first to share your experience with Moyamoya disease with early-onset achalasia.
Start the conversation →Latest news about Moyamoya disease with early-onset achalasia
No recent news articles for Moyamoya disease with early-onset achalasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is the moyamoya disease, and is surgery recommended now or should we monitor first?,What type of revascularization surgery would you recommend, and what are the risks and benefits?,What is the best treatment approach for the achalasia — dilation, surgery, or another option?,Are there any activities or situations my child should avoid to reduce stroke risk?,Should our family undergo genetic testing, and what would the results mean for other family members?,How often will my child need brain imaging and esophageal evaluations going forward?,What signs of a stroke should I watch for, and what should I do in an emergency?
Common questions about Moyamoya disease with early-onset achalasia
What is Moyamoya disease with early-onset achalasia?
Moyamoya disease with early-onset achalasia is an extremely rare condition that combines two distinct medical problems. Moyamoya disease is a condition affecting the blood vessels in the brain. In this disease, certain arteries at the base of the brain become narrowed or blocked over time. The body tries to compensate by growing tiny new blood vessels, which on imaging look like a "puff of smoke" (the Japanese meaning of "moyamoya"). This can lead to strokes, mini-strokes (called transient ischemic attacks), headaches, and seizures. Achalasia is a disorder of the esophagus — the tube that carr
How is Moyamoya disease with early-onset achalasia inherited?
Moyamoya disease with early-onset achalasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Moyamoya disease with early-onset achalasia typically begin?
Typical onset of Moyamoya disease with early-onset achalasia is childhood. Age of onset can vary across affected individuals.